Current state of commercial point-of-care nucleic acid tests for infectious diseases-Reference-Cited by-同舟云学术

Current state of commercial point-of-care nucleic acid tests for infectious diseases

Author:

Zhang Jane Y.¹²³^ORCID,Bender Andrew T.¹²³^ORCID,Boyle David S.⁴³,Drain Paul K.⁵²³⁶⁷,Posner Jonathan D.¹²³⁸⁷^ORCID

Affiliation:

1. Department of Mechanical Engineering

2. University of Washington

3. USA

4. PATH

5. Department of Global Health

6. Department of Epidemiology

7. School of Medicine

8. Department of Family Medicine

Abstract

The COVID-19 pandemic has put the spotlight on the urgent need for point-of-care nucleic acid tests (NATs) for infectious diseases.

Funder

National Institute of Biomedical Imaging and Bioengineering

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrochemistry,Spectroscopy,Environmental Chemistry,Biochemistry,Analytical Chemistry

Link

Reference67 articles.

2. R. H. Yolken , in Methods in Enzymology , ed. M. Wilchek and E. A. Bayer , Academic Press , 1990 , vol. 184 , pp. 529–537

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献